𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-α for chronic hepatitis C

✍ Scribed by Karlheinz Kiehne; Sievert Kloehn; Holger Hinrichsen; Baptist Gallwitz; Heiner Mönig


Publisher
Springer
Year
1997
Tongue
English
Weight
445 KB
Volume
6
Category
Article
ISSN
0969-711X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Autoantibodies during α-interferon thera
✍ G. Fattovich; C. Betterle; L. Brollo; B. Pedini; G. Giustina; G. Realdi; A. Albe 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive

Treatment of chronic type B hepatitis wi
✍ Werner-J. Mayet; Georg Hess; Guido Gerken; Siegbert Rossol; Rita Voth; Michael M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 1 views

Recombinant human a-interferon is now under intensive investigation as therapy for chronic Type B hepatitis. Recent reports have suggested that prolonged a- interferon therapy may induce autoimmune reactions. We have evaluated the problem of autoimmunity related to a-interferon therapy by testing fo

Treatment of children with chronic hepat
✍ Mercedes Ruiz-Moreno; Maria José Rua; Inmaculada Castillo; Maria Dolores García- 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Twelve children with chronic non-A, non-B hepatitis were entered in a pilot trial of recombinant interferon-alpha. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon-alpha 3 times/wk for 6